Less frequent pap tests safe for most women, ob/gyn group says
October 22, 2012 by Steven Reinberg, Healthday Reporter in Obstetrics & gynaecology
New guidelines recommend cervical cancer screening every 3 to 5 years.
(HealthDay)—Most women need testing for cervical cancer only every three to five years, rather than annually, according to the American College of Obstetricians and Gynecologists.
For women aged 30 and older, the Pap test, as it is called, should be done along with a test for human papillomavirus (HPV) every five years, according to new guidelines released by the organization Monday.
"The yearly Pap test was an arbitrary decision when it was recommended years ago," said Dr. David Chelmow, chairman of obstetrics and gynecology at Virginia Commonwealth University Medical Center in Richmond.
This change should reassure women, because it is scientifically based on the results of several studies, said Chelmow, who led the development of the guidelines.
The college recommended women aged 30 to 65 get an HPV test along with the Pap test because "we know HPV is the cause of most cervical cancer," Chelmow said.
If both tests are normal, no further tests are needed for five years. If the HPV test is positive, more frequent testing is needed. And if both the HPV and Pap test are positive, further testing and treatment will be done, he said.
The guidelines, published online Oct. 22 and in the November print issue of the journal Obstetrics & Gynecology, are in line with recommendations released in March by the American Cancer Society, the American Society for Colposcopy and Cervical Pathology and other medical groups.
Routine Pap testing has cut the rate of cervical cancer by more than 50 percent in the United States. "Women who develop cervical cancer are mostly those who have never been screened," Chelmow said.
According to the American Cancer Society, more than 12,000 women will be diagnosed with cervical cancer in 2012, and more than 4,000 will die from it.
For the Pap test, cells scraped from the cervix are examined under a microscope for signs of cancer or precancerous abnormalities.
Cervical cancer is caused by some types of HPV, a common sexually transmitted infection. Most women with healthy immune systems can eliminate HPV infections, but a small number with persistent HPV infection will develop cervical abnormalities that lead to cancer, Chelmow explained.
According to the new guidelines:
- Women aged 30 to 65 with normal Pap and HPV tests need screening only every five years. If only a Pap test is available, it is needed every three years.
- Women aged 21 to 29 should be screened every three years instead of every two years.
- Women under 21 do not need screening because invasive cervical cancer is rare in this age group.
- Women 65 and older don't need screening if they have no history of cervical cancer and have had three consecutive normal Pap tests or two consecutive Pap and HPV tests over a 10-year period with the latest test done within the past five years.
- Women of any age who have had a total hysterectomy, which includes removal of the cervix, and have no history of cervical cancer do not need regular screening.
- HPV-vaccinated women should follow the same screening guidelines as unvaccinated women.
- Some women need more frequent screening. They include women who have had cervical cancer, are HIV-positive, have compromised immune systems or were exposed to the drug diethylstilbestrol in the womb.
Dr. Elizabeth Poynor, a gynecologic oncologist and pelvic surgeon at Lenox Hill Hospital in New York City, said women shouldn't interpret the recommendation for less frequent Pap tests to mean they don't need an annual "well woman" visit.
"We really need to highlight to the women we treat that just because we recommend a Pap test every three to five years doesn't mean you only see your doctor every three to five years," she said.
The annual exam addresses other health and wellness concerns, she noted.
Also, women should review these recommended changes with their doctor to see how they apply to them, she said. "Women really need to discuss with their doctor how these guidelines apply specifically to them and their health history," she said.
More information: For more information on PAP and HPV tests, visit the U.S. National Cancer Institute.
Journal reference:
Obstetrics & Gynecology
Copyright © 2012 HealthDay. All rights reserved.
-
Health groups issue cervical cancer screening guidelines
Mar 14, 2012 |
not rated yet |
0
-
Study urges three-year gap in cervical cancer test
May 18, 2011 |
not rated yet |
0
-
Health groups issue proposed cervical cancer screening guidelines
Oct 19, 2011 |
not rated yet |
0
-
HPV test beats pap long-term: study
Jul 30, 2012 |
not rated yet |
0
-
Study: Docs overtesting for cervical cancer virus
Jun 20, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Electric field-Charge inside a metallic shell
2 hours ago
-
Change in momentum when a body is thrown up and falls back down.
8 hours ago
-
change in speed and wavelength of light while travelling from one med
9 hours ago
-
Calculus of Variation - Classical Mechanics
12 hours ago
-
Frictional Force Equation Doesn't Make Sense
12 hours ago
-
Calculating Steam Pressure in Closed Container
17 hours ago
- More from Physics Forums - Classical Physics
More news stories
Women's reproductive ability may be related to immune system status
New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.
Obstetrics & gynaecology
May 17, 2013 |
not rated yet |
0
|
Breakthrough for IVF?
Elsevier today announced the publication of a recent study in Reproductive BioMedicine Online on 5-day old human blastocysts showing that those with an abnormal chromosomal composition can be identified by the rate at whic ...
Obstetrics & gynaecology
May 16, 2013 |
not rated yet |
0
Non-communicable diseases account for half of adult female deaths in rural Bangladesh
While global attention has for decades been focused on reducing maternal mortality, population-based data on other causes of death among women of reproductive age has been virtually non-existent. A study conducted by researchers ...
Obstetrics & gynaecology
May 14, 2013 |
not rated yet |
0
Turkish womb transplant woman's pregnancy terminated
Doctors have terminated the pregnancy of a 23-year-old Turkish woman who was the first ever to receive a uterus transplant from a dead donor, a hospital in southern Turkey said on Tuesday.
Obstetrics & gynaecology
May 14, 2013 |
not rated yet |
0
Study questions if bed rest prevents prematurity
New research is raising fresh concern that an age-old treatment for troubled pregnancies—bed rest—doesn't seem to prevent premature birth, and might even increase that risk.
Obstetrics & gynaecology
May 14, 2013 |
not rated yet |
0
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...